Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes

A. Cortellini, A. Leonetti, A. Catino, P. Pizzutillo, B. Ricciuti, A. De Giglio, R. Chiari, P. Bordi, D. Santini, R. Giusti, M. De Tursi, D. Brocco, F. Zoratto, F. Rastelli, F. Citarella, M. Russano, M. Filetti, P. Marchetti, R. Berardi, M. TorniaiD. Cortinovis, E. Sala, C. Maggioni, A. Follador, M. Macerelli, O. Nigro, A. Tuzi, D. Iacono, M. R. Migliorino, G. Banna, G. Porzio, K. Cannita, M. G. Ferrara, E. Bria, D. Galetta, C. Ficorella, M. Tiseo

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes'. Together they form a unique fingerprint.

Medicine & Life Sciences